Top

CNS Drugs

Published in:

01-12-2000 | Disease Management

Cerebral Venous Thrombosis

A Guide to Diagnosis and Drug Treatment

Authors: Dr Frank P. K. Hsu, Gary M. Nesbit, Todd Kuether, Stanley Barnwell

Published in: CNS Drugs | Issue 6/2000

Abstract

Cerebral venous thrombosis (CVT) is a relatively rare pathological condition. The clinical presentations can be nonspecific and quite variable, frequently resulting in delayed or missed diagnosis. The symptoms include headache, nausea, vomiting, visual disturbance, altered consciousness and seizures. These symptoms are believed to be caused by increased intracranial pressure secondary to impeded venous drainage.

The diagnosis can be made with computed tomography (CT), magnetic resonant imaging (MRI) and cerebral angiography. CT is usually the initial diagnostic test that may show dense clot in the cerebral veins along with hemorrhagic venous infarctions. Empty delta sign can be seen on contrast-enhanced CT. MRI has become the preferred modality for detecting CVT; magnetic resonance angiography (MRA) and venography (MRV) are the best methods for detecting the condition. Angiography, once the standard, is now only indicated when MRI has resulted in an uncertain diagnosis or when endovascular intervention is desired.

Therapy should be directed at treating the underlying causative process and symptoms secondary to elevated intracranial pressure. Although there is no consensus regarding antithrombotic treatment, the current trend is to use intravenous heparin initially, followed by warfarin. A newer approach has been developed using interventional endovascular modalities. Local infusion of thrombolytics can be achieved by transvenous catheterisation and catheter navigation. This may offer potential advantages over the established systemic antithrombotic therapy.

Gasecki AP, Barnett HJ. Cerebral sinus and venous thrombosis. In: Carter P, Spetzler R, Hamilton M, editors. Neurovascular surgery. New York: McGraw-Hill, 1995: 35–64

Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992 (10); 87-111

Hacker H. Normal supratentorial veins and durai sinuses. In: Newton TH, Potts DG, editors. Radiology of the skull and brain. St. Louis: Mosby, 1974

Ehler H, Courville CB. Thrombosis of internal cerebral veins in infancy and childhood: review of literature and report of five cases. J Pediatr 1936; 8: 600: 233–43

Barnett HJM, Hyland HH. Non-infective intracranial venous thrombosis. Brain 1953; 76: 36: 849–51

Erez N, Babuna C, Uner A. Low incidence of thromboembolic disease. An evaluation of obstetric and gynaecologic patients in Istanbul. Obstet Gynecol 1966; 27: 833–7

Towbin A. The syndrome of latent cerebral venous thrombosis. Stroke 1973; 4: 419–30PubMedCrossRef

Scotti LN, Goldman RL, Hartman DR, et al. Venous thrombosis in infants and children. Radiology 1974; 112: 393–9PubMed

Cantti C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases.Stroke 1993; 24(12): 1880–4CrossRef

10.

Buchanan DS, Brazinsky JH. Durai sinus and cerebral venous thrombosis: incidence in young women receiving oral contraceptives. Arch Neurol 1970; 22: 440–4PubMedCrossRef

11.

Sanders MD, Hoyt WE Hypoxic ocular sequelae of carotid-cavernous fistulae: study of the causes of visual failure before and after neurosurgical treatment in a series of 25 cases. Br J Ophthalmol 1969; 53: 82–97PubMedCrossRef

12.

Kuether TA, O’Neill O, Nesbit GM, et al. Endovascular treatment of traumatic durai sinus thrombosis: case report. Neurosurgery 1998; 42(5): 1163–7PubMedCrossRef

13.

Seegers WH, Marlar RA, Walz DA. Anticoagulant effects of autoprothrombin II-A and prothrombin fragment 1. Thromb Res 1978; 13: 233–43PubMedCrossRef

14.

Dusser A, Boyer-Neumann C, Wolf M. Temporary protein C deficiency associated with cerebral arterial thrombosis in childhood. J Pediatr 1988; 113: 849–51PubMedCrossRef

15.

Pugliese D, Nicoletti G, Andreula C, et al. Combined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis: a case report. Angiology 1998; 49(5): 399–401PubMedCrossRef

16.

Dulli DA, Luzzio CC, Williams EC, et al. Cerebral venous thrombosis and activated protein C resistance [see comments]. Stroke 1996; 27(10): 1731–3PubMedCrossRef

17.

Martinelli I, Landi G, Merati G, et al. Factor V gene mutation is a risk factor for cerebral venous thrombosis [see comments]. Thromb Haemost 1996; 75(3): 393–4PubMed

18.

Vuillier F, Moulin T, Tatu L, et al. Isolated cortical vein thrombosis and activated protein C resistance [letter]. Stroke 1996; 27(8): 1440–1PubMed

19.

Deschiens MA, Conard J, Horellou MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis [see comments]. Stroke 1996; 27(10): 1724–30PubMedCrossRef

20.

Biousse V, Conard J, Brouzes C, et al. Frequency of the 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis. Stroke 1998; 29(7): 1398–400PubMedCrossRef

21.

Levine SR, Kieran S, Puzio K, et al. Cerebral venous thrombosis with lupus anticoagulants: report of two cases. Stroke 1987; 18(4): 801–4PubMedCrossRef

22.

Carhuapoma JR, Mitsias P, Levine SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997; 28(12): 2363–9PubMedCrossRef

23.

Bousser MG, Chiras J, Sauron B. Cerebral venous thrombosis: a review of 38 cases. Stroke 1985; 16: 199–213PubMedCrossRef

24.

Karabudak R, Caner H, Oztekin N. Thrombosis of intracranial venous sinuses: aetiology, clinical findings and prognosis of 56 patients. J Neurosurg Sci 1990; 34: 117–21PubMed

25.

Wechsler B, Vidailhet M, Piette JC. Cerebral venous thrombosis in Behçet’s disease: clinical study and long-term follow-up of 25 cases. Neurology 1992; 42: 614–8PubMedCrossRef

26.

Bridger S, Evans N, Parker A, et al. Multiple cerebral venous thromboses in a child with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1997; 25(5): 533–6PubMedCrossRef

27.

Derdeyn CP, Powers WJ. Isolated cortical venous thrombosis and ulcerative colitis. AJNR Am J Neuroradiol 1998; 19(3): 488–90PubMed

28.

Johns DR. Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol 1991; 86: 367–70PubMed

29.

Hammans SR, Ginsberg L. Superior saggital sinus thrombosis in Wegener’s granulomatosis. J Neurol Neurosurg Psychiatry 1989; 52: 287PubMedCrossRef

30.

Gilbert WS, Talbot FJ. Cogan’s syndrome: signs of periarteritis nodosa and cerebral venous sinus thrombosis. Arch Ophthalmol 1969; 82: 633–6PubMedCrossRef

31.

Dinubile MJ. Septic thrombosis of the cavernous sinuses. Neurological review. Arch Neurol 1988; 45: 567–74CrossRef

32.

Sekhar LN, Dujovny M, Rao GR. Carotid cavernous sinus thrombosis caused by Aspergillus fumugatus. J Neurosurg 1980; 52: 120–5PubMedCrossRef

33.

Bousser MG, Russell RR. Cerebral venous thrombosis. London: WB Saunders, 1997: 385–9

34.

Wakhloo A, Johnson B, Kraus G, et al. Cerebral sinus and venous thrombosis. In: Carter P, Spetzler R, Hamilton M, editors. Neurovascular surgery. New York: McGraw-Hill, 1995: 1337–63

35.

Toms SA, Chyatte D. Cerebral venous thrombosis. In: Welch KMA, et al., editors. Primer on cerebrovascular diseases. San Diego: Academic Press, 1997: 528–32CrossRef

36.

Fisher III W: Intracranial venous occlusive diseases. In: Tindall G, Cooper P, Barrow D, editors. The practice of neurosurgery. Baltimore: Williams and Wilkins, 1996

37.

Estanol B, Rodriguez A, Conte G. Intracra nial venous thrombosis in young women. Stroke 1979; 10: 680–4PubMedCrossRef

38.

Hommet CD, Toffol BD, Cottier JP, et al. Cerebral venous thrombosis and estrogen-progesterone therapy. Eur Neurol 1998; 39: 245–7

39.

Chiras J, Bousser MG, Meder JF. CT in cerebral thrombophlebitis. Neuroradiology 1985; 27: 145–54PubMedCrossRef

40.

Diaz JM, Schiffman JS, Urban ES, et al. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered.Acta Neurol Scand 1992; 86: 390–6PubMedCrossRef

41.

Crawford SC, Digre KB, Palmer CA, et al. Thrombosis of the deep venous drainage of the brain in adults. Arch of Neurol 1995; 52: 1101–8CrossRef

42.

Daif A, Awada A, Al-Rajeh S, et al. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke 1995; 26(7): 1193–5PubMedCrossRef

43.

Perkin GD. Cerebral venous thrombosis: developments in imaging and treatment. Neurol Neurosurg Psychiatry 1995; 59: 1–3CrossRef

44.

Krayenbühl HA. Cerebral venous and sinus thrombosis. Clin Neurosurg 1967; 14: 1–24

45.

Jacobs K, Moulin T, Bogousslavsky J, et al. The stroke syndrome of cortical vein thrombosis. Neurology 1996; 47(2): 376–82PubMedCrossRef

46.

Ford K, Sarwar M. Computed tomography of durai sinus thrombosis. AJNR AM J Neuroradiol 1981; 2: 539–43PubMed

47.

Rao KCVG, Knipp HC, Wagner EJ. CT findings in cerebral sinus and venous thrombosis. Radiology 1981; 140: 391–8PubMed

48.

Buonanno FS, Moody DM, Ball RM. CT scan finding in cerebral sinovenous occlusion. Neurology 1982; 12: 288–92

49.

Buonnano FS, Moody DM, Ball MR. Computed cranial tomographic findings in cerebral sinovenous occlusion. J Comput Assist Tomogr 1979; 2: 281–90CrossRef

50.

Shinohara Y, Yosmitoshi M, Yoshii F. Appearance and disappearance of empty delta sign in superior sagittal sinus thrombosis. Stroke 1986; 17: 1282–4PubMedCrossRef

51.

Virapongse C, Cazenave C, Quisling R. The empty delta sign: frequency and significance in 76 cases of durai sinus thrombosis. Radiology 1987; 162: 779–85PubMed

52.

Padayachee TS, Bingham JB, Graves MJ, et al. Durai sinus thrombosis: diagnosis and follow-up by magnetic angiography and imaging. Neuroradiology 1991; 33: 165–7PubMedCrossRef

53.

Rippe DJ, Boyko OB, Spritzer CE, et al. Demonstration of durai sinus occlusion by the use of MR angiography. AJNR Am J Neuroradiol 1990; 11: 199–201PubMed

54.

Tsai FY, Wang A-M, Matovich VB, et al. MR staging of acute durai sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol 1995; 16: 1021–9PubMed

55.

Tsuruda JS, Shimakawa A, Pelc NJ, et al. Durai sinus occlusion: evaluation with phase-sensitive gradient-echo MR imaging. AJNR Am J Neuroradiol 1991; 12: 481–8PubMed

56.

Yuh WTC, Simonson TM, Wang A-M, et al. Venous sinus occlusive disease: MR findings. AJNR Am J Neuroradiol 1994; 15: 309–16PubMed

57.

Halbach VV, Higashida RT, Hieshima GB, et al. Venography and venous pressure monitoring in durai sinus meningiomas. AJNR Am J Neuroradiol 1989; 10: 1209–13PubMed

58.

Canhão P, Batista P, Ferro JM. Venous transcranial Doppler in acute durai sinus thrombosis. J Neurol 1998; 245(5): 276–9PubMedCrossRef

59.

Hanley DF, Feldman E, Borel CO, et al. Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension. Stroke 1988; 19: 903–9PubMedCrossRef

60.

Eick JJ, Miller KD, Bell KA. Computed tomography of deep cerebral venous thrombosis in children. Radiology 1981; 140: 399–402PubMed

61.

Preter M, Tzourio C, Ameri A, et al. Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients. Stroke 1995; 27: 243–6CrossRef

62.

Stansfield FR. Puerperal cerebral thrombophlebitis treated by heparin. BMJ 1942; 4: 436–8CrossRef

63.

Dorndorf D, Wessel K, Kessler C, et al. Thrombosis of the right vein of Labbé: radiological and clinical findings. Neuroradiology 1993; 35: 202–4PubMedCrossRef

64.

Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597–600PubMedCrossRef

65.

de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis [see comments]. Stroke 1999; 30: 484–8PubMedCrossRef

66.

Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology 1988; 38(4): 517–22PubMedCrossRef

67.

Barnwell SL, Nesbit GM, Clark WM. Local thrombolytic therapy for cerebrovascular disease: current Oregon Health Sciences University experience (July 1991 through April 1995). J Vasc Interv Radiol 1995; 6 (6 Pt 2 Suppl.): 78S–82SPubMedCrossRef

68.

Alexander LF, Yamamoto Y, Ayoubi S. Efficacy of tissue plasminogen activator in the lysis of thrombosis of the cerebral venous sinus. Neurosurgery 1990; 26: 559–64PubMedCrossRef

69.

Castaigne P, Laplace D, Bousser MG. Superior sagittal sinus thrombosis [letter]. Arch Neurol 1977; 34: 788PubMedCrossRef

70.

Di Rocco C, Iannelli A, Leone G. Heparin-urokinase treatmnet in aseptic durai sinus thrombosis. Arch Neurol 1981; 38: 431–5PubMedCrossRef

71.

Fletcher AP, Alkjaersig N, Lewis M. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 7: 135–42PubMedCrossRef

72.

Meyer JS, Gilory J, Barnhart MI, et al. Therapeutic thrombolysis in cerebral thromboembolism: double-blind evaluation of intravenous plasmin therapy in carotid and middle cerebral artery occlusion. Neurology 1963; 13: 927–37PubMedCrossRef

73.

Vines FS, Davis DO. Clinical-radiological correlation in cerebral venous occlusive disease. Radiology 1971; 98: 9–22PubMed

74.

Scott JA, Pascuzzi RM, Hall PV, et al. Treatment of durai sinus thrombosis with local urokinase infusion. J Neurosurg 1988;68: 284–7PubMedCrossRef

75.

Higashida RT, Helmer E, Halbach VV, et al. Direct thrombolytic therapy for superior sagittal sinus thrombosis. AJNR Am J Neuroradiol 1989; 10(5 Suppl.): 4S–6S

76.

Barnwell SL, Higashida RT, Halbach VV. Direct endovascular thrombolytic therapy for durai sinus thrombosis. Neurosurgery 1991; 28: 135–42PubMedCrossRef

77.

Smith TP, Higashida RT, Barnwell SL. Treatment of durai sinus thrombosis by urokinase infusion. AJNR Am J of Neuroradiol 1994; 15: 801–7

78.

Horowitz M, Purdy P, Unwin H, et al. Treatment of durai sinus thrombosis using selective catheterization and urokinase. Ann Neurol 1995; 38(1): 58–67PubMedCrossRef

79.

Spearman MP, Jungreis CA, Whener JJ, et al. Endovascular thrombolysis in deep cerebral venous thrombosis. AJNR Am J Neuroradiol 1996; 18: 502–6

80.

Dowd CF, Malek AM, Phatouros CC, et al. Application of a rheolytic thromboectomy device in the treatment of durai sinus thrombosis: a new technique. AJNR Am J Neuroradiol 1998; 20: 568–70

81.

Tsai FY, Higashida RT, Matovich V, et al. Acute thrombosis of the intracranial durai sinus: direct thrombolytic therapy. AJNR Am J Neuroradiol 1992; 13: 1137–41PubMed

82.

Holder CA, Bell DA, Lundell AL, et al. Isolated straight sinus and deep cerebral venous thrombosis: successful treatment with local infusion of urokinase. J Neurosurg 1991; 86:704–7

83.

Rael JR, Orrison Jr WW, Baldwin N, et al. Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial hemorrhage. AJNR Am J Neuroradiol 1997; 18(7): 1238–42PubMed

84.

Smith AG, Cornblath WT, Deveikis JR Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology 1997; 48(6): 1613–9PubMedCrossRef

85.

Ray BS, Dunbar HS. Thrombosis of the durai venous sinuses as a cause of ‘pseudotumor cerebri’. Ann Surg 1951; 134: 376–86PubMed

Title: Cerebral Venous Thrombosis
A Guide to Diagnosis and Drug Treatment
Authors: Dr Frank P. K. Hsu
Gary M. Nesbit
Todd Kuether
Stanley Barnwell
Publication date: 01-12-2000
Publisher: Springer International Publishing
Published in: CNS Drugs / Issue 6/2000
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI: https://doi.org/10.2165/00023210-200014060-00002

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cerebral Venous Thrombosis

A Guide to Diagnosis and Drug Treatment

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2000

Brain Magnetic Resonance Spectroscopy

Venlafaxine Extended-Release

Pharmacokinetic Optimisation of Dopamine Receptor Agonist Therapy for Parkinson’s Disease

Trend in the Use of Antidepressant Pharmacotherapy and Diagnosis of Depression in the US

Leptin and Obesity